Inna E Tchivileva
Overview
Explore the profile of Inna E Tchivileva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
389
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tchivileva I, Ohrbach R, Fillingim R, Greenspan J, Maixner W, Slade G
Pain
. 2016 Dec;
158(1):120-129.
PMID: 27984525
While cross-sectional studies have demonstrated an association between headache and temporomandibular disorder (TMD), whether headache can predict the onset of TMD is unknown. The aims of this study were to...
12.
Hartung J, Eskew O, Wong T, Tchivileva I, Oladosu F, OBuckley S, et al.
Brain Behav Immun
. 2015 Jul;
50:196-202.
PMID: 26187567
Nuclear factor-kappa B (NF-κB) is a ubiquitously expressed protein complex regulating the transcription of genes involved in inflammation and pain. Increased NF-κB activity in immune and nervous system cells is...
13.
Slade G, Smith S, Zaykin D, Tchivileva I, Gibson D, Yuryev A, et al.
Pain
. 2013 Jul;
154(11):2335-2343.
PMID: 23867732
Human association studies of common genetic polymorphisms have identified many loci that are associated with risk of complex diseases, although individual loci typically have small effects. However, by envisaging genetic...
14.
Tchivileva I, Feng Lim P, Smith S, Slade G, Diatchenko L, McLean S, et al.
Pharmacogenet Genomics
. 2010 Mar;
20(4):239-48.
PMID: 20216107
Introduction: Three common haplotypes in the gene encoding catechol-O-methyltransferase (COMT) have been associated with pain modulation and the risk of developing chronic musculoskeletal pain, namely temporomandibular disorder (TMD). Haplotypes coding...
15.
Tchivileva I, Tan K, Gambarian M, Nackley A, Medvedev A, Romanov S, et al.
Mol Immunol
. 2009 May;
46(11-12):2256-66.
PMID: 19477016
The beta(3)-adrenergic receptor (beta(3)AR) is an essential regulator of metabolic and endocrine functions. A major cellular and clinically significant consequence of beta(3)AR activation is the substantial elevation in interleukin-6 (IL-6)...
16.
Tchivileva I, Nackley A, Qian L, Wentworth S, Conrad M, Diatchenko L
Mol Pain
. 2009 Mar;
5:13.
PMID: 19291302
Background: Catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines, has recently been implicated in the modulation of pain. Specifically, low COMT activity is associated with heightened pain perception and development of...
17.
Shabalina S, Zaykin D, Gris P, Ogurtsov A, Gauthier J, Shibata K, et al.
Hum Mol Genet
. 2008 Dec;
18(6):1037-51.
PMID: 19103668
The mu-opioid receptor (OPRM1) is the principal receptor target for both endogenous and exogenous opioid analgesics. There are substantial individual differences in human responses to painful stimuli and to opiate...
18.
Diatchenko L, Nackley A, Tchivileva I, Shabalina S, Maixner W
Trends Genet
. 2007 Nov;
23(12):605-13.
PMID: 18023497
Pain is emotionally detrimental and consciously avoided; however, it is absolutely crucial for our survival. Pain perception is one of the most complicated measurable traits because it is an aggregate...